Circulating transforming growth factor β1 and coronary artery disease

Cardiovascular Research

Volumn 34, Issue 2, 1997, Pages 404-410

  Wang, X L ^b   Liu, S X ^b   Wilcken, D E L ^a,b  

^a PRINCE HENRY HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Coronary artery disease; Fibrinogen; Human; Lipoprotein(a); TGF 1

Indexed keywords

CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR SMOOTH MUSCLE;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; SMOKING; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030994625     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00033-3     Document Type: Article

References (29)

1. MacLellan WR, Brand T, Schneider MD. Transforming growth factor-β in cardiac ontogeny and adaptation [Review]. Circ Res 1993;73:783-791.
2. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
3. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipo-protein(a) mice. Nature 1994;370:460-462.
4. Kenny D, Coughlan MG, Pagel PS, Kampine JP, Warltier DC. Transforming growth factor beta 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion. Am Heart J 1994;127:1456-1461.
5. Metcalfe JC, Grainger DJ. Transforming growth factor-beta and the protection from cardiovascular injury hypothesis [Review]. Biochem Soc Trans 1995;23:403-406.
6. Halloran BG, Prorok GD, So BJ, Baxter BT. Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner. Am J Surg 1995;170:193-197.
7. Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nature Med 1995;1:74-79.
8. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science 1988;242:97-99.
9. Gamble JR, Vadas MA. Endothelial adhesiveness for human T lymphocytes is inhibited by TGF-β. J Immunol 1991;146:1149-1154.
10. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994;93:1172-1178.
11. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1582-1592.
12. Bahaodri L, Milder J, Gold L, Botney M. Active macrophage-associated TGF-beta colocalizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol 1995;146:1140-1149.
13. Border WA, Noble NA. Fibrosis linked to TGF-β in yet another disease. J Clin Invest 1995;96:655-656.
14. Harper JR, Spiro RC, Gaarde WA, et al. Role of transforming growth factor beta and decorin in controlling fibrosis. Methods Enzymol 1994;245:241-254.
15. Ohji T, Urano H, Shirahata A, et al. Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost 1995;73:812-818.
16. Promega Corporation. Transforming growth factor β1 ELISA system. Promega Techn Bull 196 1995;1-12.
17. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). [Review]. Growth Factors 1993;8:1-9.
18. Wang XL, Tam C, McCredie RM, Wilcken DEL. Determinants of severity of coronary artery disease in Australian men and women. Circulation 1994;89:1974-1981.
19. Hafler DA, Windhagen A. Multiple sclerosis: a neuroimmunological perspective. Promega Neural Notes 1995;1:3-6.
20. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1995;1:932-937.
21. Shirai Y, Kawata S, Ito N, et al. Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma. Japan J Cancer Res 1992;83:676-679.
22. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993;328:1592-1598.
23. Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR. Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta 1995;235:11-31.
24. Hanssan JH, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor beta (TGF-beta) inhibits expression of fibrinogen and factor VII in a hepatoma cell line. Thromb Haemost 1992;67:478-483.
25. Rokita H, Szuba K. Regulation of acute phase reaction by transforming growth factor beta in cultured murine hepatocytes. Acta Biochim Pol 1991;38:241-249.
26. Cagliero E, Roth T, Taylor AW, Lorenzi M. The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta. Lab Invest 1995;73:667-673.
27. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994;93:536-542.
28. Sekine N, Yamashita N, Kojima I, Miyazaki J, Ogama E. Bimodal effect of transforming growth factor-beta on insulin secretion in MIN6 cells. Diabetes Res Clin Pract 1994;26:7-14.
29. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator [Review]. Diabetes 1995;44:1139-1146.